Pooja M.Tiwari

#mRNA #RNAtherapeutics #CRISPR #BiomedEng #Virology #Nanotechnology Passionate for #India #Science #WomenScientists

[Pooja M.Tiwari @PMTiwariPhD]

Thank you for visiting us President @CabreraAngel. We are so excited to be part of @GeorgiaTech and Biospark Labs and witnessing history! Your support means a ton! @ArnavBiotech #WeCanDoThis #ScienceSqaure

[Ángel Cabrera @CabreraAngel]

Construction is well under way at our new Science Square biotech innovation district... but we're already open for business at BioSpark Labs, a new shared lab space for startups https://t.co/9o7CUdgj2n

[Ankit Gupta @agupta]

if you're the president of a country that isn't america rn the logical takeaway from the us/fable situation is:

1) we're entering the era of AI being a controlled military technology
2) if you don't develop your own you will become a vassal state of the US or China, even more than you already are
3) if chips are not export controlled to your country you should go buy 1 million B200s right now and start making some fat offers to researchers to move to your country

[Pooja M.Tiwari @PMTiwariPhD]

A good business for @Ginkgo @jrkelly!

[TaraBull @TaraBull]

Scientists and fashion brand Enfin Levé just dropped the world’s first “T. rex leather” bag

A Jurassic Park fantasy come to life. Bidding starts today at $500,000. Absolute madness.

[Pooja M.Tiwari @PMTiwariPhD]

@daphnezohar I was offered a pre-seed with the condition to host a lavish dinner at some high end restaurant in NYC for 15, during Christmas, we had just lost our mentor and Co-founder a month before, no money, 4 yo kid, when I said I couldn’t, he called me a looser!

[Narendra Modi @narendramodi]

India’s digital infrastructure journey is gathering remarkable momentum.

AirTrunk has announced plans to invest around Rs. 3 lakh crore ($30 billion) in India, and develop 5 GW of data centre capacity. This is among the largest proposed investments in the country’s digital infrastructure ecosystem.

Such investments will strengthen India’s position as a global hub for cloud computing and AI, while generating employment opportunities, supporting local supply chains and accelerating innovation-led growth.

It is clear that the future of the world’s digital economy is increasingly being shaped in India!

[Pooja M.Tiwari @PMTiwariPhD]

@AdamDraper Some of us @ArnavBiotech !

[Pooja M.Tiwari @PMTiwariPhD]

@sulemanali Can you please share their info, I would love to pitch them Lol!

[Pooja M.Tiwari @PMTiwariPhD]

@jogin_desai @EyestemResearch @tdbgoi @narendramodi @DrJitendraSingh @karandi65 Congrats!

[Pooja M.Tiwari @PMTiwariPhD]

Mine! Not everyone is corrupt! Just the corrupt get highlighted!

[Ananya @ananyashasau]

Is there even a single person in India whose passport was made without paying a bribe? 😭

Are any of you here that lucky? And if not, how much did you have to pay?

[Roland Dunbrack 🏳️‍🌈 @rolanddunbrack.bsky.social @RolandDunbrack]

MD simulations of proteins have been around for almost 50 years (1977). What are you talking about?

[Pooja M.Tiwari @PMTiwariPhD]

Wait till you here “we’ll make better RNA drugs for everything becoz we can code”!

[Robin Sayar @rlsayar]

I'm really tired of how many Bio ML startup clones there are. No unique insight or anything. Just some version of "we'll solve bio"

[Pooja M.Tiwari @PMTiwariPhD]

Grateful for the support @Pharmadept!

[AAARNA Therapeutics @aaaRNA_Tx]

Excited to share that we've been awarded @Pharmadept's #PRIP grant to advance our #CRISPR-based #Pan-serotype #Dengue antivirals! Huge thanks to the PRIP team and @GovernmentIndia for the support! @PMTiwariPhD https://t.co/FgOmbCctKw

[Pooja M.Tiwari @PMTiwariPhD]

Times we live in! Where Hon. PM @narendramodi has to fact check a news!

[Narendra Modi @narendramodi]

This is totally false.

Not an iota of truth in this.

There is no question of putting such restrictions on foreign travel.

We remain committed to improving ‘Ease of Doing Business’ and ‘Ease of Living’ for our people.

[Lori Mills @LoriMills4CA42]

Cancer patients deserve hope, not red tape.
Unleash #ANKTIVA and NK cell therapies!

[Pooja M.Tiwari @PMTiwariPhD]

This is what delta change in medicine looks like! Now months, not days, just 48 hours! Kudos @DrMakaryFDA and @fda! With an immediate family member dealing with this, I know how it feels! Hope India picks up pace!

[Dr. Marty Makary @DrMakaryFDA]

TWO DAYS after receiving the application, FDA greenlit the new pancreatic cancer drug daraxonrasib for expanded access.

This drug has also been granted a national priority voucher, which means a full application could be reviewed in a matter of weeks instead of 10-12 months.

[Pooja M.Tiwari @PMTiwariPhD]

This could be huge! Having a close family member dealing with it, this would save so many lives!

[Mayo Clinic @MayoClinic]

A Mayo Clinic-developed artificial intelligence (AI) model can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible. The findings, published in Gut, mark a milestone in Mayo Clinic's multiyear research effort to enable earlier detection of one of the deadliest cancers.

Learn more: https://t.co/EJySSkaW3P

[Vineeta Agarwala @vintweeta]

In vivo CRISPR's first-ever ph 3 win!

@intelliatx lonvo-z hit primary + all key secondary endpoints in a ph3 study evaluating one-time treatment of pts with the rare genetic disease hereditary angioedema (HAE). One dose, 87% reduction in attack rate vs placebo, 62% of pts attack-free during the 6-mo eval (vs 11% on placebo). Rolling BLA already in.

"Edit once, treat permanently" could become reality w this therapy

https://t.co/rJ5tfdhq5E

[Pooja M.Tiwari @PMTiwariPhD]

Check out our work at @aaaRNA_Tx and @ArnavBiotech where we leverage CRISPR for infectious diseases and personalised therapeutics!

[Dr. Taslimarif Saiyed @Taslimarif_IND]

Personalized CRISPR therapies could soon reach thousands — here’s how ⁦

Carrying huge promise for Gene Therapy across the world.

@NaturePortfolio⁩ ⁦@NatureBiotech⁩ https://t.co/OETynFBPaS

[Pooja M.Tiwari @PMTiwariPhD]

Amazing news!

[U.S. FDA @US_FDA]

Today FDA approved the first-ever gene therapy for the treatment of genetic hearing loss under the National Priority Voucher Program.
✅6th approval under the National Priority Voucher Program
✅Approved 61 days after filing

https://t.co/Modecu7S50

[Pooja M.Tiwari @PMTiwariPhD]

#PowerofmRNA!

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Donna was diagnosed with pancreatic cancer at age 66 when she and her husband were visiting one of their daughters in Australia. When they returned to the U.S., they immediately came to MSK for care, where she learned she was eligible for an investigational vaccine trial, to prevent pancreatic cancer from returning after surgery.

MSK hepatopancreatobiliary surgeon Dr. @Jeffrey_Drebin, physician-scientist @TheVinodLab, and medical oncologist @EileenMOReilly walked Donna through each step.

“They described how they would take part of my tumor to make a personalized vaccine, and it sounded amazing,” Donna says. “My husband and I had a moment of concern about delaying chemotherapy, but all the doctors made me feel so comfortable that we took the leap of faith and said, ‘Go for it.’”

Over the next few months, Donna received an immunotherapy drug and eight doses of the vaccine, followed by chemotherapy, and then a final vaccine dose.

Today, Donna is 72 and recently celebrated her 50th anniversary with her husband in Sicily and spends as much time as she can with her daughters and six grandchildren.

Learn more about this clinical trial, presented at the 2026 American Association for Cancer Research Annual Meeting: https://t.co/C0IwK11OaA

#AACR26

[Pooja M.Tiwari @PMTiwariPhD]

Btw, this is me :) was a great session!

[DBT-BIRAC @BIRAC_2012]

The ongoing webinar series (Phase-II) on "The Biofoundry and Bio-manufacturing Initiative (under the BioE3 Policy)", jointly organized by DBT and BIRAC, was held on 15th April 2026. The 17th webinar of the series on "Precision Biotherapeutics-mRNA Therapeutics" witnessed an overwhelming response from different stakeholders, with more than 100+ participation.

The session was opened by Dr. Jitendra Kumar (Managing Director, BIRAC) with a welcome address highlighting the need for the integration of mRNA Therapeutics Bio-manufacturing in the Indian innovation ecosystem.

An overview of BIRAC efforts in fostering ecosystem growth in mRNA Therapeutics was elaborated by Dr. Dhiraj Kumar (Mission Director, PMU-MII, BIRAC).
Guest speakers Dr. Amit Awasthi (Senior Professor, THSTI, Faridabad) and Dr. Pooja Tiwari (Co-founder and CEO, AAARNA Therapeutics Private Limited, Bengaluru) brought in perspectives on the 'Opportunities and Challenges in Precision Biotherapeutics: mRNA therapeutics' and 'Role of Academia in fostering Precision Biotherapeutics: mRNA therapeutics', respectively.

Question & Answer session with the audience was moderated by Dr. Sujit Das (Dy. Manager, Technical Division, BIRAC) & Dr. Smita Hingane (Associate Consultant- Technical Division, BIRAC).

@DrJitendraSingh , @rajesh_gokhale Dr. @drjitendrak170 , CA Nidhi Shrivastava, Dr. anamika gambhir, Dr. Vaishali Panjabi, Dr. Amit Awasthi, @THSTIFaridabad , Dr. @PoojaSays_ , Ph.D., @aaaRNA_Tx ,Dr. Dhiraj Kumar Dr. Varshneya Singh, Dr. sarma pakala, Dr. @AmitaJo66631022 , PhD, Dr. Sujit Das, Dr. Smita Hingane, @IndiaDST , @DBTIndia , @BIRAC_2012